Peter J Leary

University Of Washington

$6,420,826

Attributed

$7,198,326

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,198,326 · 5

By mechanism

R33$4,196,049 · 2

R01$1,555,000 · 1

R61$1,447,277 · 2

Top collaborators

Sina A Gharib4 shared

Most similar at University Of Washington

Same institution · by research overlap

Ted S. Gross$10,749,527
Joanne Wang$8,239,883
Eric B Larson$50,741,279
Lauren Cirrincione$748,224
Daniel Fishbein$7,728

Others in their field

Other Emerging Leaders on “Randomized Placebo Controlled Trial”

Beth Baseler · Leidos Biomedical Research, Inc.$89,024,651
Susan Abushakra · Alzheon, Inc.$51,190,244
Yunda Huang · Fred Hutchinson Cancer Center$18,303,326
James Dale Berry · Brigham And Women'S Hospital$15,344,018
Laura McNay · Leidos Biomedical Research, Inc.$15,147,252
Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108

Research focus

Randomized Placebo Controlled TrialRight Ventricular FunctionPulmonary Arterial HypertensionProgressive DiseasePulmonary HypertensionPulmonary Vascular ResistanceInstrumentMortalityParticipantPlacebosHeartPulmonary EmphysemaCohortBiochemical MarkersAdultHeart FailureLeftMorbidity - Disease RateNew YorkCardiacPathway InteractionsPharmaceutical PreparationsHealth Related Quality Of LifeSignal Transduction